BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6885787)

  • 41. Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex.
    Mahdi F; Rehemtulla A; Van Nostrand WE; Bajaj SP; Schmaier AH
    Thromb Res; 2000 Aug; 99(3):267-76. PubMed ID: 10942793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.
    Wagner SL; Geddes JW; Cotman CW; Lau AL; Gurwitz D; Isackson PJ; Cunningham DD
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8284-8. PubMed ID: 2813392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protease nexin-1, a thrombin inhibitor, is regulated by interleukin-1 and dexamethasone in normal human fibroblasts.
    Guttridge DC; Lau AL; Cunningham DD
    J Biol Chem; 1993 Sep; 268(25):18966-74. PubMed ID: 8360185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protease nexin-2/amyloid beta-protein precursor inhibits factor Xa in the prothrombinase complex.
    Mahdi F; Van Nostrand WE; Schmaier AH
    J Biol Chem; 1995 Oct; 270(40):23468-74. PubMed ID: 7559509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protease nexin I, thrombin- and urokinase-inhibiting serpin, concentrated in normal human cerebrospinal fluid.
    Festoff BW; Rao JS; Chen M
    Neurology; 1992 Jul; 42(7):1361-6. PubMed ID: 1620346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High level expression, purification, and characterization of the Kunitz-type protease inhibitor domain of protease nexin-2/amyloid beta-protein precursor.
    Wagner SL; Siegel RS; Vedvick TS; Raschke WC; Van Nostrand WE
    Biochem Biophys Res Commun; 1992 Jul; 186(2):1138-45. PubMed ID: 1497647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roles of the heparin and low density lipid receptor-related protein-binding sites of protease nexin 1 (PN1) in urokinase-PN1 complex catabolism. The PN1 heparin-binding site mediates complex retention and degradation but not cell surface binding or internalization.
    Crisp RJ; Knauer DJ; Knauer MF
    J Biol Chem; 2000 Jun; 275(26):19628-37. PubMed ID: 10867020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A form of protease nexin I is expressed on the platelet surface during platelet activation.
    Gronke RS; Knauer DJ; Veeraraghavan S; Baker JB
    Blood; 1989 Feb; 73(2):472-8. PubMed ID: 2917187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficient catabolism of thrombin-protease nexin 1 complexes is a synergistic mechanism that requires both the LDL receptor-related protein and cell surface heparins.
    Knauer MF; Kridel SJ; Hawley SB; Knauer DJ
    J Biol Chem; 1997 Nov; 272(46):29039-45. PubMed ID: 9360977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin, and urokinase.
    Stone SR; Nick H; Hofsteenge J; Monard D
    Arch Biochem Biophys; 1987 Jan; 252(1):237-44. PubMed ID: 3813534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A fibroblast-derived urokinase-inhibitor differing from protease nexin.
    Masuzawa M; Hamazaki H; Nishioka K; Nishiyama S; Ryan TJ
    Biochem Biophys Res Commun; 1987 Dec; 149(3):866-73. PubMed ID: 3426613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protease specificity and heparin binding and activation of recombinant protease nexin I.
    Evans DL; McGrogan M; Scott RW; Carrell RW
    J Biol Chem; 1991 Nov; 266(33):22307-12. PubMed ID: 1939253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasminogen activators and their inhibitors in the neuromuscular system: II. Serpins and serpin: protease complex receptors increase during in vitro myogenesis.
    Festoff BW; Rao JS; Rayford A; Hantaï D
    J Cell Physiol; 1990 Aug; 144(2):272-9. PubMed ID: 2166058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protease nexin-1 and thrombin modulate neuronal Ca2+ homeostasis and sensitivity to glucose deprivation-induced injury.
    Smith-Swintosky VL; Zimmer S; Fenton JW; Mattson MP
    J Neurosci; 1995 Aug; 15(8):5840-50. PubMed ID: 7643224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1.
    Rovelli G; Stone SR; Guidolin A; Sommer J; Monard D
    Biochemistry; 1992 Apr; 31(13):3542-9. PubMed ID: 1554734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors.
    Hengst U; Albrecht H; Hess D; Monard D
    J Biol Chem; 2001 Jan; 276(1):535-40. PubMed ID: 11034991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of protease nexin-1 activity by heparin and heparan sulfate.
    Cunningham DD; Wagner SL; Farrell DH
    Adv Exp Med Biol; 1992; 313():297-306. PubMed ID: 1442266
    [No Abstract]   [Full Text] [Related]  

  • 58. Co-distribution of protease nexin-1 and protease nexin-2 in brains of non-human primates.
    Wagner SL; Van Nostrand WE; Lau AL; Farrow JS; Suzuki M; Bartus RT; Schuppek R; Nguyen A; Cotman CW; Cunningham DD
    Brain Res; 1993 Oct; 626(1-2):90-8. PubMed ID: 8281456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of ERK signaling upon alternative protease nexin-1 internalization mediated by syndecan-1.
    Li X; Herz J; Monard D
    J Cell Biochem; 2006 Oct; 99(3):936-51. PubMed ID: 16741952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of thrombin and protease nexin-1 on peripheral nerve regeneration.
    Lee P; Spector JG; Derby A; Roufa DG
    Ann Otol Rhinol Laryngol; 1998 Jan; 107(1):61-9. PubMed ID: 9439391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.